HLA-DM, HLA-DO and tapasin: functional similarities and differences.
about
Immunoproteomics: Mass spectrometry-based methods to study the targets of the immune responseTapasin enhances MHC class I peptide presentation according to peptide half-lifeInvolvement of clathrin and AP-2 in the trafficking of MHC class II molecules to antigen-processing compartmentsMajor histocompatibility complex class I-restricted antigen processing and presentation.The exogenous pathway for antigen presentation on major histocompatibility complex class II and CD1 molecules.Tapasin and other chaperones: models of the MHC class I loading complex.Use of proteomics to define targets of T-cell immunity.Accessory molecules in the assembly of major histocompatibility complex class I/peptide complexes: how essential are they for CD8(+) T-cell immune responses?Recognition of open conformers of classical MHC by chaperones and monoclonal antibodies.Asparaginyl endopeptidase: case history of a class II MHC compartment protease.Conformational isomers of a peptide-class II major histocompatibility complex.The double role of the endoplasmic reticulum chaperone tapasin in peptide optimization of HLA class I molecules.Clinicopathological features and CCT2 and PDIA2 expression in gallbladder squamous/adenosquamous carcinoma and gallbladder adenocarcinoma.On the biological relevance of MHC class II and B7 expression by tumour cells in melanoma metastases.TAPBPR: a new player in the MHC class I presentation pathway.Role of Sug1, a 19S proteasome ATPase, in the transcription of MHC I and the atypical MHC II molecules, HLA-DM and HLA-DO.Pandemic 2009 H1N1 Influenza Venus reporter virus reveals broad diversity of MHC class II-positive antigen-bearing cells following infection in vivo.Functional dissection of the transmembrane domains of the transporter associated with antigen processing (TAP).Modulation of antigen presentation by autoreactive B cell clones specific for GAD65 from a type I diabetic patient.Generation of a functional, soluble tapasin protein from an alternatively spliced mRNA.The modification of Tapasin enhances cytotoxic T lymphocyte activity of intracellularly delivered CTL epitopes via cytoplasmic transduction peptide.Association between human leucocyte antigen-DO polymorphisms and interferon/ribavirin treatment response in hepatitis C virus type 1 infection in Chinese population: a prospective study.Molecular Interaction and Enzymatic Activity of Macrophage Migration Inhibitory Factor with Immunorelevant Peptides
P2860
Q28238379-89C5451E-45F9-48E7-BA04-F41A2B7044E9Q28274996-78380548-59D4-41CC-96A7-80DB233A2CABQ33833534-73F8A3A2-C1D1-411D-8BEE-8BC05365E616Q34941852-2C0FFCF6-2399-4B8D-85D1-CB2B63DD9BD7Q35821240-CF776CDE-9D2D-4874-B4D3-350053DC047DQ35922740-F36FFDF3-DF2F-4B7F-A783-75C36D9A8731Q36184807-BD44443E-DD34-49CA-A6B9-2E0D35DE1EAFQ36266442-86335DDF-849B-4A9B-8A26-798AF2F8E1F7Q36266455-57982402-27E4-43E7-9637-6093979D3D15Q36266494-0EE01E1E-CD79-4BC4-9717-58A62B2A65ADQ36266513-040D08CA-EC43-48D2-A5CA-E49B1624AD1DQ36831116-17955FDE-28D3-4B03-8C2D-4D8CDBD22B60Q36952400-1E71B7DD-B2FA-42DC-841C-0BE192CB3FD0Q37354975-68E148B6-2EC2-4D81-8D21-64285FC45C2EQ38365574-116FC28C-FC51-45F3-966E-C83A0CDC4792Q39318369-7DE5CAB3-8835-439D-AFBA-7C55E7201CA1Q40052241-AEDEF6D4-835A-407F-89FD-B2C100967F0FQ40606693-05336B63-F6E2-456E-9CB2-3D4A906CFE75Q40607014-56F0A818-0C3B-48D1-A3AE-F0A85C8CB878Q40608550-4CDEFCBD-13C6-4597-B1BB-EEC5FD239EC0Q42279706-4FA773FA-62FB-4839-91BA-21FBF2CFC757Q52589250-DA256A96-39EA-45EB-9CD6-8AAEDE4DBB90Q57372149-B9C8D650-A547-41D1-B8C7-5639BA6622A6
P2860
HLA-DM, HLA-DO and tapasin: functional similarities and differences.
description
2002 nî lūn-bûn
@nan
2002 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
HLA-DM, HLA-DO and tapasin: functional similarities and differences.
@ast
HLA-DM, HLA-DO and tapasin: functional similarities and differences.
@en
HLA-DM, HLA-DO and tapasin: functional similarities and differences.
@nl
type
label
HLA-DM, HLA-DO and tapasin: functional similarities and differences.
@ast
HLA-DM, HLA-DO and tapasin: functional similarities and differences.
@en
HLA-DM, HLA-DO and tapasin: functional similarities and differences.
@nl
prefLabel
HLA-DM, HLA-DO and tapasin: functional similarities and differences.
@ast
HLA-DM, HLA-DO and tapasin: functional similarities and differences.
@en
HLA-DM, HLA-DO and tapasin: functional similarities and differences.
@nl
P2093
P1476
HLA-DM, HLA-DO and tapasin: functional similarities and differences.
@en
P2093
Frank Momburg
Günter J Hämmerling
Natalio Garbi
Pascale Brocke
P356
10.1016/S0952-7915(01)00294-1
P577
2002-02-01T00:00:00Z